Javascript must be enabled to continue!
Detecting presence of mutational signatures in cancer with confidence
View through CrossRef
AbstractCancers arise as the result of somatically acquired changes in the DNA of cancer cells. However, in addition to the mutations that confer a growth advantage, cancer genomes accumulate a large number of somatic mutations resulting from normal DNA damage and repair processes as well as mutations triggered by carcinogenic exposures or cancer related aberrations of DNA mainte-nance machinery. These mutagenic processes often produce characteristic mutational patterns called mutational signatures. Decomposition of cancer’s mutation catalog into mutations consistent with such signatures can provide valuable information about cancer etiology. However, the results from different decomposition methods are not always consistent. Hence, one needs to not only be able to decompose a patient’s mutational profile into signatures but also to establish the accuracy of such decomposition. We proposed two complementary ways of measuring confidence and stability of decomposition results and applied them to analyze mutational signatures in breast cancer genomes. We identified very stable and highly unstable signatures, as well as signatures that have been missed altogether. We also provided additional support for the novel signatures. Our results emphasize the importance of assessing the confidence and stability of inferred signature contributions. All tools developed in this paper have been implemented in an R package, calledSignatureEstimation, which is available fromhttps://www.ncbi.nlm.nih.gov/CBBresearch/Przytycka/index.cgi#signatureestimation.
Title: Detecting presence of mutational signatures in cancer with confidence
Description:
AbstractCancers arise as the result of somatically acquired changes in the DNA of cancer cells.
However, in addition to the mutations that confer a growth advantage, cancer genomes accumulate a large number of somatic mutations resulting from normal DNA damage and repair processes as well as mutations triggered by carcinogenic exposures or cancer related aberrations of DNA mainte-nance machinery.
These mutagenic processes often produce characteristic mutational patterns called mutational signatures.
Decomposition of cancer’s mutation catalog into mutations consistent with such signatures can provide valuable information about cancer etiology.
However, the results from different decomposition methods are not always consistent.
Hence, one needs to not only be able to decompose a patient’s mutational profile into signatures but also to establish the accuracy of such decomposition.
We proposed two complementary ways of measuring confidence and stability of decomposition results and applied them to analyze mutational signatures in breast cancer genomes.
We identified very stable and highly unstable signatures, as well as signatures that have been missed altogether.
We also provided additional support for the novel signatures.
Our results emphasize the importance of assessing the confidence and stability of inferred signature contributions.
All tools developed in this paper have been implemented in an R package, calledSignatureEstimation, which is available fromhttps://www.
ncbi.
nlm.
nih.
gov/CBBresearch/Przytycka/index.
cgi#signatureestimation.
Related Results
Mutational signatures for breast cancer diagnosis using artificial intelligence
Mutational signatures for breast cancer diagnosis using artificial intelligence
Abstract
Background
Breast cancer is the most common female cancer worldwide. Its diagnosis and prognosis remain scanty, imprecise, and poorly docum...
Correlation of Mutational Signatures in Cancer Genes with General Signatures
Correlation of Mutational Signatures in Cancer Genes with General Signatures
The occurrence of various mutation patterns, such as changes in the DNA sequence and the loss of some sequences, is called a “mutational signature,” and they represent the molecula...
Mutational signatures are markers of drug sensitivity of cancer cells
Mutational signatures are markers of drug sensitivity of cancer cells
AbstractGenomic analyses have revealed mutational signatures that are associated with DNA maintenance gone awry, a common occurrence in tumors. Because cancer therapeutics often ta...
Abstract 1508: Chromatin accessibility of primary human cancers ties regional mutational processes with tissues of origin
Abstract 1508: Chromatin accessibility of primary human cancers ties regional mutational processes with tissues of origin
Abstract
Cancer genomes are shaped by mutational processes with complex spatial variation at multiple scales. However, the underlying mechanisms of this mutagenesis ...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Abstract A44: Directing personalized breast cancer treatment with pathway signatures
Abstract A44: Directing personalized breast cancer treatment with pathway signatures
Abstract
One of the major limitations in the treatment of breast cancer is the patient to patient heterogeneity of the tumors. This is evidenced by the well-known in...
Abstract B8: Molecular subtyping of epithelial ovarian cancer reveals connections to intrinsic breast cancer subtypes
Abstract B8: Molecular subtyping of epithelial ovarian cancer reveals connections to intrinsic breast cancer subtypes
Abstract
Aim: Epithelial ovarian cancer is one of the most lethal female cancers. It is a heterogeneous group of neoplasms and the different histologic subtypes are ...

